Evidence map›Paper›PMID 20450413›Full record

Trial reportClimacteric : the journal of the International Menopause Society2011

Modeling hot flushes and quality of life in breast cancer survivors.

K L Rand, J L Otte, D Flockhart, D Hayes, A M Storniolo, V Stearns, N L Henry, A Nguyen, S Lemler, J Hayden and 2 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Climacteric : the journal of the International Menopause Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2012
    Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Adverse Effects of Aromatase Inhibition on the Brain and Behavior in a Nonhuman Primate.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  13. Review
  14. Factors associated with poor sleep quality in women with cancer.Revista latino-americana de enfermagem · 2017
    Article
  15. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

K L RandDepartment of Psychology, Indiana University-Purdue University, Indianapolis.
J L Otte
D Flockhart
D Hayes
A M Storniolo
V Stearns
N L Henry
A Nguyen
S Lemler
J Hayden
S Jeter
J S Carpenter
Indiana University · USUniversity of Michigan–Ann Arbor · USIndiana University Bloomington · USIndiana University – Purdue University Indianapolis · USJohns Hopkins University · USSidney Kimmel Comprehensive Cancer Center · US

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELSTROM, REBECCA L · 1985 to 2007
$40.8M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI MARSH, LAURA · 1985 to 2007
$37.3M
ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI STORNIOLO, ANNA · 1985 to 2008
$25.5M
TAMAXIFEN PHARMACOGENETICSU01GM061373 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI FLOCKHART, DAVID ALASTAIR · 2000 to 2009
$17.0M
Indiana University Comprehensive Training in Clinical PharmacologyT32GM008425 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Zeruesenay Desta, Michael Thomas Eadon · 1992 to 2026
$7.7M
NCRR NIH HHS M01 RR000042NCRR NIH HHS M01 RR000052NCRR NIH HHS M01-RR00042NCRR NIH HHS M01-RR00052NCRR NIH HHS M01 RR000750NCRR NIH HHS M01RR00750NIGMS NIH HHS 5T32-GM08425NIGMS NIH HHS T32 GM008425NIGMS NIH HHS U01 GM061373NIGMS NIH HHS U01 GM61373
6 · The paper itself

Abstract

objectivesTo evaluate the relationships among measures of hot flushes, perceived hot flush interference, sleep disturbance, and measures of quality of life while controlling for potential covariates (patient and treatment variables).

methodsBreast cancer survivors (n = 395) due to receive aromatase inhibitor therapy provided demographic information, physiological hot flush data via sternal skin conductance monitoring, hot flush frequency via written diary and electronic event marker, hot flush severity and bother via written diary, and questionnaire data via the Hot Flash Related Daily Interference Scale, Pittsburgh Sleep Quality Index, the EuroQOL, Hospital Anxiety and Depression Scale and the Center for Epidemiologic Studies Depression Scale.

resultsConfirmatory factor analysis supported a two-factor model for hot flush symptoms (frequency and severity). Although there was strong convergence among self-reported hot flush measures, there was a high degree of unexplained variance associated with physiological measures. This suggests that self-report and physiological measures do not overlap substantially. The structural model showed that greater hot flush frequency and severity were directly related to greater perceived interference with daily life activities. Greater perceived interference, in turn, directly predicted greater sleep disruption, which predicted lower perceived health state and more symptoms of anxiety and depression.

conclusionsFindings suggest hot flush interference may be the most appropriate single measure to include in clinical trials of vasomotor symptom therapies. Measuring and ameliorating patients' perceptions of hot flush interference with life activities and subjective sleep quality may be the most direct routes to improving quality of life.

Indexed as

Factor Analysis, StatisticalModels, BiologicalQuality of LifeAnxietyAromatase InhibitorsBreast NeoplasmsDepressionFemaleGalvanic Skin ResponseHealth StatusHot FlashesHumansMiddle AgedMonitoring, AmbulatorySeverity of Illness IndexSleep Wake DisordersAromatase Inhibitors

Identifiers

PMID20450413
PMCPMC3022093
OpenAlexW2125830429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.